Garg Vipin K's Form 4 filing
Altimmune, Inc. (ALT) · filed Sep 1, 2022
- Accession no.
- 0001104659-22-097013
- Filed
- Sep 1, 2022
- Trade date
- Aug 30-31, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $400.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Garg Vipin KCIK 0001515813 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2022 | Common Stock, par value $0.0001 | FTax withholdingDisposed | −3,007 | $18.94 | −$56,952.58 | 256,797 | Direct | |
| Aug 31, 2022 | Common Stock, par value $0.0001 | SSaleDisposed | −20,000 | $20.02 | −$400,400 | 236,797 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.